IQVIA: Increasingly Indispensable In Drug Development [Seeking Alpha]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Seeking Alpha
Long-term revenue visibility is underpinned by a record $32.4B backlog, technology-driven margin expansion, and robust buyback-enhanced EPS growth. IQV's unique, comprehensive data assets and AI-enabled services create a defensible moat, insulating it from both Big Tech and CRO competition. With 5% revenue growth, high single-digit EPS growth, and a 20–30% upside to a $285/share fair value, IQV offers durable, compounding returns. Love Employee/iStock via Getty Images Investment Thesis The scale of IQVIA Holdings ( IQV ) in healthcare information, real-world evidence collection, and AI-enabled trials and commercialization make it much more than a large CRO. Other CROs compete for share within the contract research This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses m
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA (NYSE:IQV) was given a new $230.00 price target on by analysts at Barclays PLC.MarketBeat
- Amphastar Announces FDA Approval for Teriparatide Injection [Yahoo! Finance]Yahoo! Finance
- Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here's what to know [CNBC]CNBC
- Moderna (MRNA) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 12/9/25 - Form 8-K
- 11/14/25 - Form 3
- 11/7/25 - Form 4
- IQV's page on the SEC website